Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Anti-ageing therapies

Biotech Innovation in the Time of COVID-19

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Impetus Digital

- PMLiVE

eureKARE to use $60m financing to bolster next-generation European biotech companies

New company is focused on financing biotech companies and new ventures in Europe working on the microbiome and synthetic biology

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics

Leading biotechnology company NovaBiotics Ltd have secured a major licensing deal for their fungal nail treatment

Onyx Health

Newcells Biotech secures over £5m for 3D tissue models

Newcells Biotech have received multi-million investment to develop their pioneering 3D tissue models

Onyx Health

- PMLiVE

UK biotech Synairgen treats first patient in phase 3 COVID-19 trial

SNG001 delivers an inhaled formulation of Interferon-beta-1a directly to the lungs

- PMLiVE

New medical communications agency BOLDSCIENCE launches

The new global agency boldly sets out its plans to become a major player in med comms

BOLDSCIENCE

Virtual Reality in Medicine and Clinical Research

In the latest episode of Impetus Digital's Fireside Chat, I sit down with Ville Leppälä, Vertical Lead, Research and Medical, at Varjo. We discuss the potential applications of virtual reality, augmented...

Impetus Digital

VR/AR Applications for Training and Healthcare

In the latest episode of Impetus Digital's Fireside Chat, I sit down with Mike Waldron, who is the CEO and Co-Founder of Propel VR. We discuss how virtual reality (VR)...

Impetus Digital

- PMLiVE

Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

Includes measures to help businesses disrupted by the pandemic

- PMLiVE

ReNeuron set for recovery after Woodford stake sale

Edison analyst says sale should help shares to stabilise

- PMLiVE

A snapshot of Congenica

PME talks to CEO David Atkins

- PMLiVE

UK biotech funding falls 40% between 2018 and 2019

Drop attributed to global uncertainty and Neil Woodford scandal

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links